Black Rock Inc. Kempharm, Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Kempharm, Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,397,847 shares of KMPH stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,397,847

Previous 2,410,289 0.52%

Holding current value

$11.8 Million

Previous $11.9 Million 0.51%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	N/A	-12,442 Reduced 0.52%	2,397,847 $11.8 Million
Q4 2023 Feb 13, 2024	BUY	N/A	259,839 Added 12.08%	2,410,289 $11.9 Million
Q3 2023 Nov 13, 2023	SELL	N/A	-52,627 Reduced 2.39%	2,150,450 $10.6 Million
Q2 2023 Aug 11, 2023	BUY	$4.94 - $6.29 $7.9 Million - $10.1 Million	1,599,899 Added 265.24%	2,203,077 $10.9 Million
Q1 2023 May 12, 2023	BUY	$4.13 - $6.27 $2,011 - $3,053	487 Added 0.08%	603,178 $3.32 Million

Q4 2022 Feb 13, 2023	SELL	$4.12 - $5.62 $1.01 Million - $1.38 Million	-244,920 Reduced 28.9%	602,691 $2.77 Million
Q3 2022 Nov 14, 2022	SELL	$4.5 - $6.85 $23,571 - $35,880	-5,238 Reduced 0.61%	847,611 $5.29 Million
Q2 2022 Aug 12, 2022	SELL	$4.02 - $5.21 $5.63 Million - $7.3 Million	-1,400,485 Reduced 62.15%	852,849 $3.8 Million
Q1 2022 May 12, 2022	BUY	$5.0 - $9.26 $88,960 - $164,753	17,792 Added 0.8%	2,253,334 $11.3 Million
Q4 2021 Feb 10, 2022	BUY	$7.6 - $10.26 $2.1 Million - $2.83 Million	276,104 Added 14.09%	2,235,542 $19.5 Million
Q3 2021 Nov 09, 2021	SELL	$8.72 - $13.31 $77,956 - $118,991	-8,940 Reduced 0.45%	1,959,438 $18.3 Million
Q2 2021 Aug 11, 2021	BUY	$8.52 - $15.47 $16.8 Million - $30.5 Million	1,968,378 New	1,968,378 $25.2 Million

Others Institutions Holding KMPH

# of Institutions

Shares Held

13.8M

Call Options Held

68.1K

Put Options Held

42K

View Full List

About KEMPHARM, INC

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

More about KMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account